147 related articles for article (PubMed ID: 26034396)
1. Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.
Kast RE
Contemp Oncol (Pozn); 2015; 19(2):157-62. PubMed ID: 26034396
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of melatonin agonists.
Cardinali DP; Pandi-Perumal SR; Srinivasan V; Spence DW; Trakht I
Expert Rev Endocrinol Metab; 2008 Mar; 3(2):269-279. PubMed ID: 30764095
[TBL] [Abstract][Full Text] [Related]
3. Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.
Srinivasan V; Zakaria R; Othaman Z; Brzezinski A; Prasad A; Brown GM
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):180-9. PubMed ID: 22483286
[TBL] [Abstract][Full Text] [Related]
4. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
[TBL] [Abstract][Full Text] [Related]
5. New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists.
Hardeland R
Neuropsychiatr Dis Treat; 2009; 5():341-54. PubMed ID: 19557144
[TBL] [Abstract][Full Text] [Related]
6. The role of melatonin and its analogues in epilepsy.
Khan S; Khurana M; Vyas P; Vohora D
Rev Neurosci; 2020 Sep; ():. PubMed ID: 32950966
[TBL] [Abstract][Full Text] [Related]
7. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
[TBL] [Abstract][Full Text] [Related]
8. Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders.
Rivara S; Mor M; Bedini A; Spadoni G; Tarzia G
Curr Top Med Chem; 2008; 8(11):954-68. PubMed ID: 18673165
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs-disulfiram and ritonavir.
Kast RE
Chin J Cancer; 2015 Apr; 34(4):161-5. PubMed ID: 25963312
[TBL] [Abstract][Full Text] [Related]
10. Searching for new options for treating insomnia: are melatonin and ramelteon beneficial?
Bellon A
J Psychiatr Pract; 2006 Jul; 12(4):229-43. PubMed ID: 16883148
[TBL] [Abstract][Full Text] [Related]
11. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis.
Fink T; Glas M; Wolf A; Kleber A; Reus E; Wolff M; Kiefer D; Wolf B; Rensing H; Volk T; Mathes AM
Crit Care Med; 2014 Jan; 42(1):e22-31. PubMed ID: 24145838
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of duration of action of melatonin agonists on melatonin MT1 receptor: possible link between duration of action and dissociation rate from receptor.
Nishiyama K; Hirai K
Eur J Pharmacol; 2015 Jun; 757():42-52. PubMed ID: 25797281
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
14. A Review of Melatonin, Its Receptors and Drugs.
Emet M; Ozcan H; Ozel L; Yayla M; Halici Z; Hacimuftuoglu A
Eurasian J Med; 2016 Jun; 48(2):135-41. PubMed ID: 27551178
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of melatonin receptor agonists.
Paulis L; Simko F; Laudon M
Expert Opin Investig Drugs; 2012 Nov; 21(11):1661-78. PubMed ID: 22916799
[TBL] [Abstract][Full Text] [Related]
16. Circadian Rhythm and Melatonin in the Treatment of Depression.
Satyanarayanan SK; Su H; Lin YW; Su KP
Curr Pharm Des; 2018; 24(22):2549-2555. PubMed ID: 30073921
[TBL] [Abstract][Full Text] [Related]
17. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
Kato K; Hirai K; Nishiyama K; Uchikawa O; Fukatsu K; Ohkawa S; Kawamata Y; Hinuma S; Miyamoto M
Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
[TBL] [Abstract][Full Text] [Related]
18. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
Fisher SP; Davidson K; Kulla A; Sugden D
J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
[TBL] [Abstract][Full Text] [Related]
19. Ramelteon: a review of its therapeutic potential in sleep disorders.
Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.
Imbesi M; Uz T; Dzitoyeva S; Manev H
Neurosci Lett; 2008 Jul; 439(1):34-6. PubMed ID: 18501512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
